Paul Sabbatini
保罗·萨巴蒂尼
MD
Deputy Physician-in-Chief for Clinical Research临床研究副主任医师
👥Biography 个人简介
Leading researcher in ovarian cancer immunotherapy and therapeutic vaccine development at MSKCC. Has led pioneering work on carbohydrate-based vaccines and immunologic approaches targeting ovarian cancer antigens, with extensive early-phase trial leadership.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Therapeutic Cancer Vaccines
Developed and clinically tested carbohydrate-conjugate vaccines targeting Globo-H and MUC-1 antigens expressed on ovarian cancer cells.
Ovarian Cancer Immunotherapy
Conducted early-phase trials combining checkpoint inhibitors with standard chemotherapy in platinum-resistant and recurrent ovarian cancer.
Clinical Trial Innovation
As Deputy Physician-in-Chief, oversees MSKCC's early clinical trials program spanning over 200 active oncology studies.
Representative Works 代表性著作
Phase I study of a Globo-H-KLH vaccine in patients with relapsed epithelial ovarian cancer
Clinical Cancer Research (2007)
Demonstrated immunogenicity and safety of carbohydrate vaccine approach for ovarian cancer, establishing foundation for further development.
Immunologic response to cancer vaccines in ovarian cancer patients
Journal of Clinical Oncology (2012)
Characterized immune responses to vaccination strategies and identified correlates of clinical benefit in ovarian cancer.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Bradley J. Monk
University of Arizona / HonorHealth
Kathleen N. Moore
Stephenson Cancer Center, University of Oklahoma
Ana Oaknin
Vall d'Hebron University Hospital
Shannon Neville Westin
The University of Texas MD Anderson Cancer Center
关注 保罗·萨巴蒂尼 的研究动态
Follow Paul Sabbatini's research updates
留下邮箱，当我们发布与 Paul Sabbatini（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment